Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fed Conditions
NCT00803764
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
34
Enrollment
INDUSTRY
Sponsor class
Conditions
Bioequivalency
Interventions
DRUG:
Naproxen Tablets, 500 mg
Sponsor
Perrigo Company